Dimensional Fund Advisors LP Cyclerion Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.47 - $1.29 $21,177 - $58,124	-45,058 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.96 - $1.78 $73,736 - $136,720	-76,809 Reduced 63.03%	45,058 $50,000
Q4 2021 Feb 09, 2022	SELL	$1.56 - $2.99 $25,103 - $48,115	-16,092 Reduced 11.66%	121,867 $210,000
Q3 2021 Nov 12, 2021	SELL	$2.73 - $4.13 $57,425 - $86,874	-21,035 Reduced 13.23%	137,959 $424,000
Q2 2021 Aug 12, 2021	BUY	$2.18 - $4.29 $213,336 - $419,823	97,861 Added 160.08%	158,994 $620,000
Q1 2021 May 14, 2021	SELL	$2.69 - $5.12 $6,999 - $13,322	-2,602 Reduced 4.08%	61,133 $171,000
Q4 2020 Feb 25, 2021	BUY	$2.25 - $7.12 $143,403 - $453,793	63,735 New	63,735 $195,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $76.1M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.